Tirzepatide 10MG

Revolutionary Dual-Agonist for Metabolic Control

$115.95$95.95

Out of stock

Tirzepatide represents a paradigm shift in metabolic research and weight management. As a dual GIP and GLP-1 receptor agonist, it uniquely targets two distinct hormonal pathways to optimize glucose homeostasis, enhance insulin sensitivity, and address complex metabolic markers including sleep apnea.

Unlike single-receptor options, Tirzepatide’s dual-action mechanism drives superior efficacy. In clinical trials, this compound has demonstrated profound results, facilitating substantial improvements in body composition with documented weight reductions of up to 22% over 72 weeks, establishing a new benchmark in metabolic science.

Ultra-Pure Formulation: 10mg of pure Tirzepatide (99%+ purity)

Disclaimer: Sold as a lyophilized powder. This product is exclusively intended for laboratory research and development use. It is not a drug, food, or cosmetic and must not be misbranded or misused. Usage is strictly limited to non-human, in-vitro research applications and is not approved for human or veterinary consumption, therapy, or diagnosis. All information provided is for educational and scientific reference only.